NICE Does Not Recommend Combination Treatment for Multiple Myeloma

NICE does not recommend daratumumab plus bortezomib, thalidomide and dexamethasone, for the management of untreated multiple myeloma in adults who are eligible for an autologous HSCT.

from Ob/Gyn & Women’s Health – Medscape http://www.medscape.com/viewarticle/957363
via IFTTT

robotic surgeon, gynecologic cancer treatment center, holistic oncologist

Design a site like this with WordPress.com
Get started